Ralph Braun

Ralph Braun is an accomplished professional in the field of biology and vaccine development, currently serving as Vice President of Biology at AstraZeneca since February 2024, after a tenure in the same role at Icosavax, Inc. from August 2022 to February 2024. Prior to these positions, Ralph Braun held various senior roles at Takeda from October 2014 to August 2022, focusing on virus-like particle cloning and assay development for Norovirus and Chikungunya. Experience also includes a significant period at Pfizer/Wyeth as a Principal Research Scientist, emphasizing assay development and GxP compliant clinical testing. Earlier career highlights include leadership in developing a DNA vaccine against HSV-2 at PowderJect Vaccines and research into DNA vaccines for large animals at the Veterinary Infectious Disease Organization. Ralph Braun's scientific journey began with a postdoctoral fellowship at Queen's University and a study of hormone action at Insect Biotech Canada. Educationally, Ralph Braun earned a Ph.D. in Biochemistry from the University of Saskatchewan.